Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 116   

Articles published

4502 4,678.00 +8.00 (0.17%)
price chart
Global Market Study on Sleep Aids: Sleep Apnea to Witness Highest Growth by 2020
Some of the major players in the sleep aids market are Sanofi, Merck & Co., Pfizer, Koninklijke Philips N.V. (Philips), GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Care Fusion Corporation, Teva Pharmaceutical Industries Ltd. Cadwell, ...
Takeda talks to buy Valeant's Salix stalls, sources say
Takeda Pharmaceutical Co. Ltd.'s negotiations to acquire Valeant Pharmaceuticals International Inc.'s Salix stomach-drug business have stalled over price disagreements, people familiar with the matter said on Wednesday.
Takeda's talks to acquire Valeant's Salix stall: sources  Reuters
Valeant Pharmaceuticals Intl Inc (VRX) To Retain Salix Pharmaceuticals, Ltd ...  Insider Monkey (blog)
Takeda to Invest More Than 100 Million Euros in Dengue Vaccine Manufacturing ...
KONSTANZ, Germany & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) (“Takeda”) today announced that it will invest more than 100 Million Euros to build a new manufacturing plant for its dengue vaccine ...
Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Trial ...
CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the Phase 3 ALCANZA clinical trial evaluating ...
Seattle Genetics Presents Data from Phase 2 Study Evaluating ADCETRIS ...  Yahoo Sports
Takeda and Koneksa Health Announce Strategic Collaboration to Use Digital ...
CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Koneksa Health, Inc. (“Koneksa”), an early stage company focused on the integration of real world data into clinical research, ...
Cerevance Launched with New Technology, Drug Portfolio and $36M in Cash to ...
Takeda Pharmaceutical Company Limited (TOKYO:4502) and Lightstone Ventures today announced the launch of Cerevance, a neuroscience company focused on discovering and developing novel therapeutics for neurological and psychiatric disorders.
TSX hits 18-month high as energy stocks surge higher with oil prices
Valeant Pharmaceuticals International Inc fell 7.9 percent to C$21.24 as sources said talks to sell a stomach drug business to Takeda Pharmaceutical Co Ltd have stalled. Gold miners also weighed as bullion prices fell. Barrick Gold Corp dropped 2.9 ...
Takeda CEO talks globalization, innovation in pharmaceutical industry
Christophe Weber, president and CEO of Takeda Pharmaceutical Company Ltd., brings a global vision, a multicultural perspective, and a long-term approach to running the 235-year-old Japanese company.
Valeant Pharmaceuticals International needs to do a lot more than just cry ...
Valeant is the asset seller that cried “wolf.” Every couple of weeks, it seems, a new Valeant Pharmaceuticals International Inc. asset is reported to be up for sale as the company seeks to pay down some of its US$30 billion in debt.
Valeant: If It Quacks Like A Duck, It's A Duck  Seeking Alpha
Takeda's IBD Treatment ENTYVIO� (vedolizumab) Receives Prestigious Prix Galien ...
Additional information about Takeda is available at takeda.com. Takeda Canada, located in Oakville, Ontario, is the Canadian sales and marketing organization of Takeda Pharmaceutical Company Limited. Takeda Canada is transforming to become an agile ...